DIM
DC Investments Management Portfolio holdings
AUM
$240M
This Quarter Return
+0.56%
1 Year Return
+17.11%
3 Year Return
+33.53%
5 Year Return
+148.92%
10 Year Return
–
AUM
$172M
AUM Growth
+$172M
(-3.5%)
Cap. Flow
-$5.38M
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
21.38%
Holding
368
New
43
Increased
87
Reduced
134
Closed
65
Top Buys
| 1 |
Marathon Petroleum
MPC
|
$2.33M |
| 2 |
Valero Energy
VLO
|
$2.11M |
| 3 |
Evolent Health
EVH
|
$2.04M |
| 4 |
Phillips 66
PSX
|
$1.93M |
| 5 |
InMode
INMD
|
$951K |
Top Sells
| 1 |
Milestone Pharmaceuticals
MIST
|
$1.06M |
| 2 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
$926K |
| 3 |
Goldman Sachs
GS
|
$866K |
| 4 |
Zoom
ZM
|
$859K |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$845K |
Sector Composition
| 1 | Healthcare | 18.21% |
| 2 | Energy | 15.61% |
| 3 | Financials | 14.98% |
| 4 | Technology | 11.26% |
| 5 | Utilities | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Par Pacific Holdings
PARR
$1.76B
| $11.7M | 6.79% |
511,378
| – | – |
|
2
Chemours
CC
$2.31B
| $5.36M | 3.11% |
358,782
| – | – |
|
3
Delek US
DK
$1.67B
| $5.08M | 2.95% |
139,880
| – | – |
|
|
4
Evolent Health
EVH
$1.12B
| $3.35M | 1.94% |
465,717
+284,119
| +156% | +$2.04M |
|
5
Alcoa
AA
$8.33B
| $2.85M | 1.65% |
141,959
| – | – |
|
|
6
Marathon Petroleum
MPC
$54.6B
| $2.33M | 1.35% |
+38,391
| New | +$2.33M |
|
|
7
Valero Energy
VLO
$47.2B
| $2.11M | 1.22% |
+24,747
| New | +$2.11M |
|
|
8
Phillips 66
PSX
$54B
| $1.93M | 1.12% |
+18,890
| New | +$1.93M |
|
9
Medtronic
MDT
$119B
| $1.11M | 0.64% |
10,177
-1,077
| -10% | -$117K |
|
10
Novo Nordisk
NVO
$251B
| $1.03M | 0.6% |
19,990
+2,714
| +16% | +$140K |
|
11
Smith & Nephew
SNN
$16.3B
| $1.01M | 0.59% |
21,008
-1,807
| -8% | -$87K |
|
12
Coca-Cola Europacific Partners
CCEP
$40.4B
| $959K | 0.56% |
17,290
+524
| +3% | +$29.1K |
|
|
13
InMode
INMD
$944M
| $951K | 0.55% |
+44,216
| New | +$951K |
|
14
Novartis
NVS
$245B
| $945K | 0.55% |
10,876
| – | – |
|
15
Accenture
ACN
$162B
| $924K | 0.54% |
4,805
-367
| -7% | -$70.6K |
|
16
AstraZeneca
AZN
$248B
| $921K | 0.53% |
20,654
| – | – |
|
17
IBM
IBM
$227B
| $895K | 0.52% |
6,155
+4,607
| +298% | +$670K |
|
18
Steris
STE
$24.1B
| $860K | 0.5% |
5,954
-744
| -11% | -$107K |
|
|
FSCT
19
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $841K | 0.49% |
22,190
+3,914
| +21% | +$148K |
|
20
Sanofi
SNY
$121B
| $836K | 0.49% |
18,048
-5,064
| -22% | -$235K |
|
21
Varonis Systems
VRNS
$6.61B
| $804K | 0.47% |
13,447
+2,010
| +18% | +$120K |
|
22
Rapid7
RPD
$1.34B
| $767K | 0.45% |
16,887
+2,593
| +18% | +$118K |
|
23
Palo Alto Networks
PANW
$127B
| $763K | 0.44% |
3,741
+700
| +23% | +$143K |
|
24
Fortinet
FTNT
$60.4B
| $758K | 0.44% |
9,880
+1,722
| +21% | +$132K |
|
25
GSK
GSK
$79.9B
| $752K | 0.44% |
17,613
-5,134
| -23% | -$219K |
|